Susquehanna International Group, LLP Precigen, Inc. Transaction History

Susquehanna International Group, LLP

$688 Billion
Q2 2025

A detailed history of Susquehanna International Group, LLP transactions in Precigen, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 1,139,702 shares of PGEN stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,139,702

Previous 164,458 593.0%

Holding current value

$2.05 Million

Previous $245,000 560.41%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.17 - $1.62 $1.14 Million - $1.58 Million	975,244 Added 593.0%	1,139,702 $1.62 Million
Q1 2025 May 14, 2025	SELL	$1.07 - $2.03 $578,265 - $1.1 Million	-540,435 Reduced 76.67%	164,458 $245,000
Q4 2024 Feb 14, 2025	BUY	$0.67 - $1.12 $438,925 - $733,726	655,113 Added 1316.02%	704,893 $789,000
Q3 2024 Nov 14, 2024	SELL	$0.91 - $1.88 $83,595 - $172,702	-91,863 Reduced 64.86%	49,780 $47,000
Q2 2024 Aug 15, 2024	BUY	$1.27 - $1.75 $179,886 - $247,875	141,643 New	141,643 $223,000
Q4 2023 Feb 14, 2024	SELL	$0.89 - $1.41 $54,692 - $86,647	-61,452 Reduced 40.43%	90,561 $121,000
Q3 2023 Nov 14, 2023	BUY	$1.08 - $1.85 $84,628 - $144,966	78,360 Added 106.39%	152,013 $215,000
Q2 2023 Aug 11, 2023	SELL	$0.96 - $1.4 $56,818 - $82,860	-59,186 Reduced 44.55%	73,653 $84,000
Q1 2023 May 16, 2023	BUY	$0.88 - $2.19 $17,678 - $43,994	20,089 Added 17.82%	132,839 $140,000
Q4 2022 Feb 14, 2023	BUY	$1.27 - $2.26 $31,625 - $56,278	24,902 Added 28.35%	112,750 $171,000
Q3 2022 Nov 14, 2022	SELL	$1.41 - $2.79 $192,328 - $380,564	-136,403 Reduced 60.83%	87,848 $186,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $2.53 $62,065 - $136,544	-53,970 Reduced 19.4%	224,251 $300,000
Q1 2022 May 16, 2022	SELL	$1.91 - $3.98 $831,438 - $1.73 Million	-435,308 Reduced 61.01%	278,221 $587,000
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $396,704 - $618,095	112,381 Added 18.69%	713,529 $2.65 Million
Q3 2021 Nov 15, 2021	BUY	$4.99 - $6.55 $519,369 - $681,737	104,082 Added 20.94%	601,148 $3 Million
Q2 2021 Aug 11, 2021	BUY	$6.24 - $8.22 $4,380 - $5,770	702 Added 0.14%	497,066 $3.24 Million
Q1 2021 May 17, 2021	SELL	$6.74 - $10.95 $2.72 Million - $4.42 Million	-403,998 Reduced 44.87%	496,364 $3.42 Million
Q4 2020 Feb 16, 2021	BUY	$3.75 - $10.56 $1.34 Million - $3.77 Million	357,201 Added 65.76%	900,362 $9.18 Million
Q3 2020 Nov 16, 2020	SELL	$3.5 - $6.2 $222,393 - $393,954	-63,541 Reduced 10.47%	543,161 $1.9 Million
Q2 2020 Aug 14, 2020	BUY	$2.16 - $5.46 $408,112 - $1.03 Million	188,941 Added 45.23%	606,702 $3.03 Million
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $609,931 - $3 Million	417,761 New	417,761 $1.42 Million

Others Institutions Holding PGEN

# of Institutions

164

Shares Held

164M

Call Options Held

516K

Put Options Held

964K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $375M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Precigen, Inc. Transaction History